中国组织工程研究 ›› 2016, Vol. 20 ›› Issue (43): 6451-6457.doi: 10.3969/j.issn.2095-4344.2016.43.010

• 组织工程骨及软骨材料 tissue-engineered bone and cartilage materials • 上一篇    下一篇

等离子体处理聚氨酯-胶原-硫酸软骨素复合材料的制备及性能评价

玄光善1,穆兰兰1,孙  桐1,李  青2
  

  1. 1青岛科技大学药学系,山东省青岛市  266000;2青岛中皓生物工程有限公司,山东省青岛市  266000
  • 收稿日期:2016-08-04 出版日期:2016-10-21 发布日期:2016-10-21
  • 作者简介:玄光善,男,1964年生,吉林省延吉市人,朝鲜族,2001年庆北大学毕业,博士,教授,主要从事药物分析及医药用生物材料研究。

A plasma-modified polyurethane-collagen-chondroitin sulfate composite material: preparation and performance

Xuan Guang-shan1, Mu Lan-lan1, Sun Tong1, Li Qing2
  

  1. 1Department of Pharmacy, Qingdao University of Science and Technology, Qingdao 266000, Shandong Province, China; 2Qingdao ChungHao Tissue Engineering Company, Qingdao 266000, Shandong Province, China
  • Received:2016-08-04 Online:2016-10-21 Published:2016-10-21
  • About author:Xuan Guang-shan, Doctor, Professor, Department of Pharmacy, Qingdao University of Science and Technology, Qingdao 266000, Shandong Province, China

摘要:

文章快速阅读:

 

文题释义:
聚氨酯材料
:是具有微相分离结构的弹性聚合物,具有优异的机械性能、良好的生物相容性(包括血液相容性),分子设计自由度大,改变其结构中软硬段的组成及配比,可得到不同硬度、机械性能的产物,所以被认为是最佳综合性能的生物医学合成材料,并且被广泛用于人工心脏、人工皮肤、药物载体、人工血管等领域。
硫酸软骨素:在伤口愈合中起到重要作用,它可保持纤维和细胞间水分,促进炎症细胞迁移和营养成分迁移,且降解产物无毒,可为细胞提供碳源和氮源,增加细胞的信使核糖核酸和脱氧核糖核酸的生物合成,促进细胞代谢,加速伤口愈合。故将其用在皮肤支架材料上,可显著提高材料生物性能。

背景:聚氨酯具有优异的机械性能和良好的生物相容性,但其疏水性不利于细胞黏附生长,故限制了聚氨酯在皮肤支架上的应用。
目的:对聚氨酯支架材料进行改性,观察其形态结构,检测其亲水性、机械性能及细胞毒性。
方法:通过静电纺丝方法制备聚氨酯支架材料,然后进行CO2、NH3等离子体处理,最后通过交联剂交联,与胶原蛋白及硫酸软骨素复合,制备等离子体处理聚氨酯-胶原-硫酸软骨素复合材料,设置为A组;设置3组对照,聚氨酯经静电纺丝后进行等离子体处理制备成支架材料后,浸泡在未加交联剂的胶原硫酸软骨素混合溶液中,取出风干,设为B组;聚氨酯经静电纺丝后进行等离子体处理,制备成支架材料,设为C组;将聚氨酯进行静电纺丝,制备成支架材料,设为D组。对比4组材料的形态结构、亲水性、机械性能及体外细胞毒性。
结果与结论:等离子体处理聚氨酯-胶原-硫酸软骨素复合材料具有良好的纤维形貌、亲水性及机械性能,可促进细胞的黏附、增殖,无细胞毒性。

关键词: 生物材料, 材料相容性, 等离子体, 聚氨酯, 胶原, 硫酸软骨素, 复合材料, 细胞毒性, 生物相容性

Abstract:

BACKGROUND: Polyurethane has excellent mechanical properties and perfect biocompatibility. But its hydrophobicity is not conductive to the adhesion and growth of cells, which limits its use as the scaffold of the skin.
OBJECTIVE: To modify a polyurethane scaffold by plasma processing and crosslinking then to test its hydrophilic, mechanical properties and cytotoxicity in vitro.
METHODS: Polyurethane porous materials were prepared into membranous materials by eletrospinning method and modified by CO2 and NH3 plasma. Then the plasma-modified polyurethane-collagen- chondroitin sulfate composite materials were prepared by crosslinking with collagen type I and chondroitin sulfate at the same time, which was named Group A. Polyurethane porous materials which were electrospun and modified by plasma were soaked into a mixed solution of collagen and chondroitin sulfate without crosslinking agent. After being air-dryed, the materials were prepared, named Group B. Polyurethane porous materials which were electrospun and modified by plasma were named Group C. Electrospun polyurethane porous materials without other treatments were named Group D. Then the morphology, hydrophilicity, mechanical property and in vitro cytotoxicity of the four groups were compared.
RESULTS AND CONCLUSION: The plasma-modified polyurethane-collagen-chondroitin sulfate composite materials enjoy excellent fiber morphology, hydrophilicity and mechanical properties. It can also promote cell adhesion, proliferation and have no cytotoxicity.

Key words: Collagen, Chondroitin Sulfates, Tissue Engineering

中图分类号: